Papers
17
Total Citations
357
H-Index
11
About
Clara Cerrato is a leading urologic surgeon and researcher whose work focuses on advancing minimally invasive treatments for kidney and prostate cancers. Her primary research areas include robot-assisted partial nephrectomy (RAPN), percutaneous tumor ablation, and complex renal mass management. Dr. Cerrato has made landmark contributions by systematically evaluating RAPN outcomes for the most challenging renal tumors—including completely endophytic, hilar, large (cT2-T3), and solitary kidney masses—demonstrating that robotic surgery can be safely expanded to these high-risk indications. Her multicenter trifecta analyses comparing RAPN to percutaneous ablation for endophytic tumors have provided crucial evidence guiding treatment selection, with her most-cited papers accumulating over 350 citations. Notably, she leads the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group, a multicenter initiative generating comparative oncological outcomes for complex renal masses. Dr. Cerrato has also investigated prognostic factors in prostate cancer surgery, including the impact of advanced age, extended lymph node dissection, and positive surgical margins on patient outcomes. Her work consistently bridges surgical innovation with rigorous evidence synthesis, establishing benchmarks for complex robotic urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10